首页 > 最新文献

Revista clinica espanola最新文献

英文 中文
Ética e inteligencia artificial 情感与人工智能
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-03-01 DOI: 10.1016/j.rce.2024.01.007
L. Inglada Galiana , L. Corral Gudino , P. Miramontes González

The relationship between ethics and artificial intelligence in medicine is a crucial and complex topic that falls within its broader context. Ethics in medical artificial intelligence involves ensuring that technologies are safe, fair, and respect patient privacy. This includes concerns about the accuracy of diagnoses provided by artificial intelligence, fairness in patient treatment, and protection of personal health data.

Advances in artificial intelligence can significantly improve healthcare, from more accurate diagnoses to personalized treatments. However, it is essential that developments in medical artificial intelligence are carried out with strong ethical consideration, involving healthcare professionals, artificial intelligence experts, patients, and ethics specialists to guide and oversee their implementation.

Finally, transparency in artificial intelligence algorithms and ongoing training for medical professionals are fundamental.

医学伦理与人工智能之间的关系是一个关键而复杂的话题,属于其更广泛的范畴。医学人工智能的伦理涉及确保技术安全、公平并尊重患者隐私。这包括对人工智能提供的诊断准确性、患者治疗的公平性以及个人健康数据的保护等问题的关注。人工智能的进步可以极大地改善医疗保健,从更准确的诊断到个性化的治疗。然而,医疗人工智能的发展必须要有强烈的伦理考虑,要有医疗专业人员、人工智能专家、患者和伦理专家的参与,以指导和监督其实施。最后,人工智能算法的透明度和对医疗专业人员的持续培训也是至关重要的。
{"title":"Ética e inteligencia artificial","authors":"L. Inglada Galiana ,&nbsp;L. Corral Gudino ,&nbsp;P. Miramontes González","doi":"10.1016/j.rce.2024.01.007","DOIUrl":"https://doi.org/10.1016/j.rce.2024.01.007","url":null,"abstract":"<div><p>The relationship between ethics and artificial intelligence in medicine is a crucial and complex topic that falls within its broader context. Ethics in medical artificial intelligence involves ensuring that technologies are safe, fair, and respect patient privacy. This includes concerns about the accuracy of diagnoses provided by artificial intelligence, fairness in patient treatment, and protection of personal health data.</p><p>Advances in artificial intelligence can significantly improve healthcare, from more accurate diagnoses to personalized treatments. However, it is essential that developments in medical artificial intelligence are carried out with strong ethical consideration, involving healthcare professionals, artificial intelligence experts, patients, and ethics specialists to guide and oversee their implementation.</p><p>Finally, transparency in artificial intelligence algorithms and ongoing training for medical professionals are fundamental.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140062568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La exploración física con ultrasonidos, luces y sombras de un avance multidisciplinar imparable 体格检查与超声波、光与影,势不可挡的多学科进展
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-03-01 DOI: 10.1016/j.rce.2023.11.012
Y. Tung-Chen , M. Martí-de Gracia
{"title":"La exploración física con ultrasonidos, luces y sombras de un avance multidisciplinar imparable","authors":"Y. Tung-Chen ,&nbsp;M. Martí-de Gracia","doi":"10.1016/j.rce.2023.11.012","DOIUrl":"https://doi.org/10.1016/j.rce.2023.11.012","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140062569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efecto de un equipo multidisciplinar (código TEP) en el pronóstico de los pacientes con tromboembolia de pulmón aguda sintomática 多学科团队(PET 代码)对急性无症状肺血栓栓塞症患者预后的影响
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-03-01 DOI: 10.1016/j.rce.2024.01.004
S. González , M. Najarro , W. Briceño , C. Rodríguez , D. Barrios , R. Morillo , A. Olavarría , A. Lietor , V. Gómez del Olmo , Á. Osorio , Á. Sánchez-Recalde , A. Muriel , D. Jiménez

Background

The effect of a pulmonary embolism response team (PERT) in the short-term prognosis of patients with acute symptomatic pulmonary embolism (PE) lacks clarity. We therefore aimed at evaluating the effect of a PERT team on short-term mortality among patients with acute PE.

Methods

We retrospectively reviewed consecutive patients with acute symptomatic PE enrolled in a single-center registry between 2007 and 2022. We used propensity score matching to compare treatment effects for patients with similar predicted probabilities of receiving management by the PERT team. The primary outcome was all-cause mortality within 30 days following the diagnosis of PE. The secondary outcome was 30-day PE-related mortality.

Results

Of the 2,902 eligible patients who had acute symptomatic PE, 223 (7.7%; 95% confidence interval [CI], 6.7%-8.7%) were managed by the PERT team. Two hundred and seven patients who were treated by the PERT were matched with 207 patients who were not. Matched pairs did not show a statistically significant lower all-cause (odds ratio [OR], 1.09; 95% CI, 0.63-1.89) or PE-related death (OR, 1.30; 95% CI, 0.47-3.62) for PERT management compared with no PERT management through 30 days after diagnosis of PE.

Conclusions

Our results suggest that multidisciplinary care of patients with acute symptomatic PE by a PERT team is not associated with a significant reduction in short-term all-cause or PE-related mortality.

背景肺栓塞应对小组(PERT)对急性无症状肺栓塞(PE)患者短期预后的影响尚不明确。因此,我们旨在评估肺栓塞应对小组对急性肺栓塞患者短期死亡率的影响。方法我们回顾性分析了 2007 年至 2022 年间在单中心登记处登记的连续急性症状性肺栓塞患者。我们使用倾向评分匹配法比较了接受 PERT 团队治疗的预测概率相似的患者的治疗效果。主要结果是确诊 PE 后 30 天内的全因死亡率。结果 在 2902 名符合条件的急性症状 PE 患者中,有 223 人(7.7%;95% 置信区间 [CI],6.7%-8.7%)接受了 PERT 团队的治疗。接受 PERT 治疗的 277 名患者与未接受 PERT 治疗的 207 名患者进行了配对。与诊断 PE 后 30 天内未接受 PERT 治疗的患者相比,接受 PERT 治疗的患者全因死亡(几率比 [OR],1.09;95% 置信区间 [CI],0.63-1.89)或 PE 相关死亡(OR,1.30;95% 置信区间 [CI],0.47-3.62)均无统计学意义。
{"title":"Efecto de un equipo multidisciplinar (código TEP) en el pronóstico de los pacientes con tromboembolia de pulmón aguda sintomática","authors":"S. González ,&nbsp;M. Najarro ,&nbsp;W. Briceño ,&nbsp;C. Rodríguez ,&nbsp;D. Barrios ,&nbsp;R. Morillo ,&nbsp;A. Olavarría ,&nbsp;A. Lietor ,&nbsp;V. Gómez del Olmo ,&nbsp;Á. Osorio ,&nbsp;Á. Sánchez-Recalde ,&nbsp;A. Muriel ,&nbsp;D. Jiménez","doi":"10.1016/j.rce.2024.01.004","DOIUrl":"https://doi.org/10.1016/j.rce.2024.01.004","url":null,"abstract":"<div><h3>Background</h3><p>The effect of a pulmonary embolism response team (PERT) in the short-term prognosis of patients with acute symptomatic pulmonary embolism (PE) lacks clarity. We therefore aimed at evaluating the effect of a PERT team on short-term mortality among patients with acute PE.</p></div><div><h3>Methods</h3><p>We retrospectively reviewed consecutive patients with acute symptomatic PE enrolled in a single-center registry between 2007 and 2022. We used propensity score matching to compare treatment effects for patients with similar predicted probabilities of receiving management by the PERT team. The primary outcome was all-cause mortality within 30 days following the diagnosis of PE. The secondary outcome was 30-day PE-related mortality.</p></div><div><h3>Results</h3><p>Of the 2,902 eligible patients who had acute symptomatic PE, 223 (7.7%; 95% confidence interval [CI], 6.7%-8.7%) were managed by the PERT team. Two hundred and seven patients who were treated by the PERT were matched with 207 patients who were not. Matched pairs did not show a statistically significant lower all-cause (odds ratio [OR], 1.09; 95% CI, 0.63-1.89) or PE-related death (OR, 1.30; 95% CI, 0.47-3.62) for PERT management compared with no PERT management through 30 days after diagnosis of PE.</p></div><div><h3>Conclusions</h3><p>Our results suggest that multidisciplinary care of patients with acute symptomatic PE by a PERT team is not associated with a significant reduction in short-term all-cause or PE-related mortality.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140062564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto de la malnutrición en la calidad de vida de los pacientes ancianos con insuficiencia cardíaca avanzada 营养不良对晚期心力衰竭老年患者生活质量的影响
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2024.01.001
J.-M. Verdu-Rotellar , E. Calero , J. Duran , E. Navas , S. Alonso , N. Argemí , M. Casademunt , P. Furió , E. Casajuana , E. Vinyoles , M.A. Muñoz , en representación del estudio HADES

Objectives

The aim of this study was to assess the prevalence of malnutrition, the clinical characteristics associated with malnutrition and the impact of nutritional status on mortality, quality of life, self-care abilities, and activities of daily living in the older patients with advanced heart failure.

Methods

A prospective multicentre cohort study including 260 community-dwelling elderly patients with advanced heart failure was conducted between June 2017 and December 2019. The study was carried out in 22 primary healthcare centres, three university hospitals, one acute-care hospital, and one geriatric rehabilitation unit in the city of Barcelona (Spain). Nutritional status was assessed at baseline using the Mini Nutritional Assessment (MNA) questionnaire. Patient-reported outcome measures included quality of life (EQ-5D-3L), self-care behaviour (European Heart Failure Self-care Behaviour Scale) and impact on activities of daily living (Barthel index).

Results

Using the MNA-SF, 126 (48.5%) patients were identified as being at risk of malnutrition and 33 (12.7%) patients as having confirmed malnutrition. Compared to heart failure patients with normal nutritional status, patients with confirmed malnutrition were significantly older, with a lower BMI, and with reduced haemoglobin levels. During follow-up (median 14.9 months, interquartile range: 4.9-26.9), 133 (51.2%) of the included participants died, and mortality was significantly higher among patients identified as having malnutrition (P < .001). Better Barthel index and quality of life scores were inversely related to the risk of malnutrition (Odds Ratio [OR] 0.97 [95% confidence interval: 0.96 to 0.98] and OR 0.98 [95% confidence interval: 0.96 to 0.99]), respectively. Higher scores in the European Heart Failure Self-care Behaviour Scale, which implies worse self care, were related to higher malnutrition risk (OR 1.05 [95% confidence interval: 1.02 to 1.09]). Adjusted multivariate logistic model found that malnutrition was significantly associated with poor quality of life, and adverse impacts on daily activities and self-care.

Conclusions

In community-dwelling older patients with advanced heart failure, malnutrition was associated with worse patient reported outcome measures related to poor quality of life, and adverse impacts on self-care and daily activities. Nutritional status must be systematically addressed by primary care nurses and family doctors to improve survival rates in these patients. It would be helpful the incorporation of expert professionals in nutrition in the primary health care centres.

目的 本研究旨在评估晚期心力衰竭老年患者营养不良的发生率、与营养不良相关的临床特征以及营养状况对死亡率、生活质量、自理能力和日常生活活动的影响。方法 在2017年6月至2019年12月期间开展了一项前瞻性多中心队列研究,纳入了260名社区居住的晚期心力衰竭老年患者。研究在巴塞罗那市(西班牙)的22家初级医疗保健中心、3家大学医院、1家急诊医院和1家老年康复中心进行。基线营养状况使用迷你营养评估(MNA)问卷进行评估。患者报告的结果指标包括生活质量(EQ-5D-3L)、自我护理行为(欧洲心力衰竭自我护理行为量表)和对日常生活活动的影响(巴特尔指数)。结果通过MNA-SF,126名(48.5%)患者被确定为有营养不良风险,33名(12.7%)患者被确定为营养不良。与营养状况正常的心衰患者相比,确诊营养不良的患者年龄明显偏大,体重指数较低,血红蛋白水平也有所下降。在随访期间(中位数为14.9个月,四分位数间距为4.9-26.9),133名参与者(51.2%)死亡,被确认为营养不良的患者死亡率明显更高(P <.001)。较好的巴特尔指数和生活质量评分与营养不良的风险成反比(Odds Ratio [OR] 0.97 [95% 置信区间:0.96 至 0.98] 和 OR 0.98 [95% 置信区间:0.96 至 0.99])。欧洲心力衰竭自理行为量表的得分越高,意味着自理能力越差,营养不良风险越高(OR 1.05 [95% 置信区间:1.02 至 1.09])。结论 在社区居住的老年晚期心力衰竭患者中,营养不良与患者报告的生活质量较差的相关结果指标以及对自我护理和日常活动的不利影响有关。初级保健护士和家庭医生必须系统地处理营养状况问题,以提高这些患者的存活率。在初级保健中心纳入营养方面的专业人员将很有帮助。
{"title":"Impacto de la malnutrición en la calidad de vida de los pacientes ancianos con insuficiencia cardíaca avanzada","authors":"J.-M. Verdu-Rotellar ,&nbsp;E. Calero ,&nbsp;J. Duran ,&nbsp;E. Navas ,&nbsp;S. Alonso ,&nbsp;N. Argemí ,&nbsp;M. Casademunt ,&nbsp;P. Furió ,&nbsp;E. Casajuana ,&nbsp;E. Vinyoles ,&nbsp;M.A. Muñoz ,&nbsp;en representación del estudio HADES","doi":"10.1016/j.rce.2024.01.001","DOIUrl":"https://doi.org/10.1016/j.rce.2024.01.001","url":null,"abstract":"<div><h3>Objectives</h3><p>The aim of this study was to assess the prevalence of malnutrition, the clinical characteristics associated with malnutrition and the impact of nutritional status on mortality, quality of life, self-care abilities, and activities of daily living in the older patients with advanced heart failure.</p></div><div><h3>Methods</h3><p>A prospective multicentre cohort study including 260 community-dwelling elderly patients with advanced heart failure was conducted between June 2017 and December 2019. The study was carried out in 22 primary healthcare centres, three university hospitals, one acute-care hospital, and one geriatric rehabilitation unit in the city of Barcelona (Spain). Nutritional status was assessed at baseline using the Mini Nutritional Assessment (MNA) questionnaire. Patient-reported outcome measures included quality of life (EQ-5D-3L), self-care behaviour (European Heart Failure Self-care Behaviour Scale) and impact on activities of daily living (Barthel index).</p></div><div><h3>Results</h3><p>Using the MNA-SF, 126 (48.5%) patients were identified as being at risk of malnutrition and 33 (12.7%) patients as having confirmed malnutrition. Compared to heart failure patients with normal nutritional status, patients with confirmed malnutrition were significantly older, with a lower BMI, and with reduced haemoglobin levels. During follow-up (median 14.9 months, interquartile range: 4.9-26.9), 133 (51.2%) of the included participants died, and mortality was significantly higher among patients identified as having malnutrition (<em>P</em> <!-->&lt;<!--> <!-->.001). Better Barthel index and quality of life scores were inversely related to the risk of malnutrition (Odds Ratio [OR] 0.97 [95% confidence interval: 0.96 to 0.98] and OR 0.98 [95% confidence interval: 0.96 to 0.99]), respectively. Higher scores in the European Heart Failure Self-care Behaviour Scale, which implies worse self care, were related to higher malnutrition risk (OR 1.05 [95% confidence interval: 1.02 to 1.09]). Adjusted multivariate logistic model found that malnutrition was significantly associated with poor quality of life, and adverse impacts on daily activities and self-care.</p></div><div><h3>Conclusions</h3><p>In community-dwelling older patients with advanced heart failure, malnutrition was associated with worse patient reported outcome measures related to poor quality of life, and adverse impacts on self-care and daily activities. Nutritional status must be systematically addressed by primary care nurses and family doctors to improve survival rates in these patients. It would be helpful the incorporation of expert professionals in nutrition in the primary health care centres.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparidades en función de sexo en los ensayos clínicos 临床试验中的性别差异
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2023.12.001
J. Ena
{"title":"Disparidades en función de sexo en los ensayos clínicos","authors":"J. Ena","doi":"10.1016/j.rce.2023.12.001","DOIUrl":"https://doi.org/10.1016/j.rce.2023.12.001","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalencia de enfermedad renal crónica en personas con diabetes tipo 1. Estudio multicéntrico en Castilla-La Mancha, España 1 型糖尿病患者慢性肾病的患病率。西班牙卡斯蒂利亚-拉曼恰地区的多中心研究。
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2023.08.005
M. Gallach Martínez , M. Jara Vidal , A. Ruiz de Assín Valverde , P.J. Pinés Corrales
{"title":"Prevalencia de enfermedad renal crónica en personas con diabetes tipo 1. Estudio multicéntrico en Castilla-La Mancha, España","authors":"M. Gallach Martínez ,&nbsp;M. Jara Vidal ,&nbsp;A. Ruiz de Assín Valverde ,&nbsp;P.J. Pinés Corrales","doi":"10.1016/j.rce.2023.08.005","DOIUrl":"https://doi.org/10.1016/j.rce.2023.08.005","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diferencias en función del sexo en las características clínicas y resultados del ensayo clínico CLOROTIC (combinación de diuréticos de asa con tiazidas en la insuficiencia cardiaca descompensada) CLOROTIC(襻利尿剂与噻嗪类药物联合治疗失代偿性心力衰竭)临床试验的临床特征和结果中的性别差异
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2023.11.011
A. Conde-Martel , J.C. Trullàs , J.L. Morales-Rull , J. Casado , M. Carrera-Izquierdo , M. Sánchez-Marteles , P. Llácer , P. Salamanca-Bautista , L. Manzano , F. Formiga

Aims

The addition of hydrochlorothiazide (HCTZ) to furosemide improved the diuretic response in patients with acute heart failure (AHF) in the CLOROTIC trial. Our aim was to evaluate if there were differences in clinical characteristics and outcomes according to sex.

Methods

This is a post hoc analysis of the CLOROTIC trial, including 230 patients with AHF randomized to receive HCTZ or placebo in addition to an intravenous furosemide regimen. The primary and secondary outcomes included changes in weight and patient-reported dyspnoea 72 and 96 h after randomization, metrics of diuretic response and mortality/rehospitalizations at 30 and 90 days. The influence of sex on primary, secondary and safety outcomes was evaluated.

Results

One hundred and eleven (48%) women were included in the study. Women were older and had higher values of left ventricular ejection fraction. Men had more ischemic cardiomyopathy and chronic obstructive pulmonary disease and higher values of natriuretic peptides. The addition of HCTZ to furosemide was associated to a greatest weight loss at 72/96 h, better metrics of diuretic response and higher 24-h diuresis compared to placebo without significant differences according to sex (all P-values for interaction were not significant). Worsening renal function occurred more frequently in women (OR: 8.68; 95% CI: 3.41-24.63) than men (OR: 2.5; 95% CI: 0.99-4.87), P = .027. There were no differences in mortality or rehospitalizations at 30/90 days.

Conclusion

Adding HCTZ to intravenous furosemide is an effective strategy to improve diuretic response in AHF with no difference according to sex, but worsening renal function was more frequent in women.

目的在CLOROTIC试验中,在呋塞米基础上加用氢氯噻嗪(HCTZ)可改善急性心力衰竭(AHF)患者的利尿反应。我们的目的是评估不同性别患者的临床特征和结果是否存在差异。方法这是一项对 CLOROTIC 试验的事后分析,该试验包括 230 名急性心力衰竭患者,他们在静脉注射呋塞米方案的同时随机接受 HCTZ 或安慰剂治疗。主要和次要结果包括随机化后72和96小时体重和患者报告的呼吸困难的变化、利尿剂反应指标以及30和90天的死亡率/再住院率。研究还评估了性别对主要、次要和安全性结果的影响。女性年龄较大,左心室射血分数较高。男性患缺血性心肌病和慢性阻塞性肺病的人数较多,钠尿肽的数值也较高。与安慰剂相比,在呋塞米基础上加用 HCTZ 的 72/96 小时体重减轻幅度最大,利尿反应指标更好,24 小时利尿率更高,但性别差异不显著(所有交互作用的 P 值均不显著)。女性肾功能恶化的发生率(OR:8.68;95% CI:3.41-24.63)高于男性(OR:2.5;95% CI:0.99-4.87),P = 0.027。结论 在静脉注射呋塞米的基础上添加 HCTZ 是改善 AHF 利尿反应的有效策略,与性别无关,但女性肾功能恶化的发生率更高。
{"title":"Diferencias en función del sexo en las características clínicas y resultados del ensayo clínico CLOROTIC (combinación de diuréticos de asa con tiazidas en la insuficiencia cardiaca descompensada)","authors":"A. Conde-Martel ,&nbsp;J.C. Trullàs ,&nbsp;J.L. Morales-Rull ,&nbsp;J. Casado ,&nbsp;M. Carrera-Izquierdo ,&nbsp;M. Sánchez-Marteles ,&nbsp;P. Llácer ,&nbsp;P. Salamanca-Bautista ,&nbsp;L. Manzano ,&nbsp;F. Formiga","doi":"10.1016/j.rce.2023.11.011","DOIUrl":"https://doi.org/10.1016/j.rce.2023.11.011","url":null,"abstract":"<div><h3>Aims</h3><p>The addition of hydrochlorothiazide (HCTZ) to furosemide improved the diuretic response in patients with acute heart failure (AHF) in the CLOROTIC trial. Our aim was to evaluate if there were differences in clinical characteristics and outcomes according to sex.</p></div><div><h3>Methods</h3><p>This is a post hoc analysis of the CLOROTIC trial, including 230 patients with AHF randomized to receive HCTZ or placebo in addition to an intravenous furosemide regimen. The primary and secondary outcomes included changes in weight and patient-reported dyspnoea 72 and 96<!--> <!-->h after randomization, metrics of diuretic response and mortality/rehospitalizations at 30 and 90<!--> <!-->days. The influence of sex on primary, secondary and safety outcomes was evaluated.</p></div><div><h3>Results</h3><p>One hundred and eleven (48%) women were included in the study. Women were older and had higher values of left ventricular ejection fraction. Men had more ischemic cardiomyopathy and chronic obstructive pulmonary disease and higher values of natriuretic peptides. The addition of HCTZ to furosemide was associated to a greatest weight loss at 72/96<!--> <!-->h, better metrics of diuretic response and higher 24-h diuresis compared to placebo without significant differences according to sex (all <em>P</em>-values for interaction were not significant). Worsening renal function occurred more frequently in women (OR: 8.68; 95%<!--> <!-->CI: 3.41-24.63) than men (OR: 2.5; 95%<!--> <!-->CI: 0.99-4.87), <em>P</em> <!-->=<!--> <!-->.027. There were no differences in mortality or rehospitalizations at 30/90<!--> <!-->days.</p></div><div><h3>Conclusion</h3><p>Adding HCTZ to intravenous furosemide is an effective strategy to improve diuretic response in AHF with no difference according to sex, but worsening renal function was more frequent in women.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carta al editor sobre el artículo «Papel del Doppler de la vena femoral en pacientes con insuficiencia cardiaca aguda: resultados de un estudio multicéntrico prospectivo» 就文章 "股静脉多普勒在急性心力衰竭患者中的作用:一项前瞻性多中心研究的结果 "致编辑的信。
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2023.09.008
A. Gil-Rodrigo , M.-J. Luque-Hernández , C. Martínez Buendía , R. Escribano-Castillo
{"title":"Carta al editor sobre el artículo «Papel del Doppler de la vena femoral en pacientes con insuficiencia cardiaca aguda: resultados de un estudio multicéntrico prospectivo»","authors":"A. Gil-Rodrigo ,&nbsp;M.-J. Luque-Hernández ,&nbsp;C. Martínez Buendía ,&nbsp;R. Escribano-Castillo","doi":"10.1016/j.rce.2023.09.008","DOIUrl":"10.1016/j.rce.2023.09.008","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139633466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cuidados paliativos geriátricos en demencia avanzada 晚期痴呆症的老年姑息治疗
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2023.09.009
D.S. Marín-Medina , H. Bautista-Mier , D.M. Perilla-Orozco , J.A. Sánchez-Duque
{"title":"Cuidados paliativos geriátricos en demencia avanzada","authors":"D.S. Marín-Medina ,&nbsp;H. Bautista-Mier ,&nbsp;D.M. Perilla-Orozco ,&nbsp;J.A. Sánchez-Duque","doi":"10.1016/j.rce.2023.09.009","DOIUrl":"10.1016/j.rce.2023.09.009","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139634910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factores predictivos del riesgo de fractura de cadera osteoporótica en octogenarios 八旬老人骨质疏松性髋部骨折风险的预测因素
IF 2.9 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.rce.2023.11.010
A. Capdevila-Reniu , M. Navarro-López , V. Sapena , A.I. Jordan , M. Arroyo-Huidobro , A. López-Soto

Objective

This study aims to identify the risk factors associated with osteoporotic hip fractures in octogenarians and seeks to refine primary prevention strategies for these fractures.

Material and methods

We conducted a case–control study involving individuals aged 79 years and older with hip fractures, comparing them to age- and sex-matched controls without a history of hip fractures. We collected epidemiological, clinical, anthropometric, and analytical factors. We evaluated the presence of osteoporosis using bone densitometry. We defined sarcopenia according the European Working Group on Sarcopenia in Older People criteria (EWGSOP2).

Results

Ninety-five patients per group were analyzed, with a mean age of 82 years, of which 74% were women. The multivariate analysis included statistically significant factors found in the univariate analysis (P<.05). These factors included the Barthel Index, nutritional assessment using the CONUT tool, folic acid, vitamin D deficiency, presence of previous fractures, loss of visual acuity, bicipital circumference, sarcopenia, and osteoporosis (densitometry in the neck of the femur). The nutritional state (OR: 0.08 [0.01–0.61]), the folic acid levels (OR 0.32 [0.1–1]), and a loss of visual acuity (OR 33.16 [2.91–377.87]) were the independent risk factors associated with hip fracture.

Conclusions

The assessment of nutritional status in elderly patients, coupled with a comprehensive geriatric assessment, represents easily reproducible and cost-effective tools. These tools can effectively aid in identifying individuals at risk of hip fractures, thereby contributing to more targeted and efficient preventive measures.

材料和方法 我们进行了一项病例对照研究,研究对象是 79 岁及以上的髋部骨折患者,并将他们与无髋部骨折史的年龄和性别匹配的对照组进行了比较。我们收集了流行病学、临床、人体测量和分析因素。我们使用骨密度测量法评估是否存在骨质疏松症。我们根据欧洲老年人肌肉疏松症工作组标准(EWGSOP2)对肌肉疏松症进行了定义。多变量分析包括单变量分析中发现的具有统计学意义的因素(P< .05)。这些因素包括巴特尔指数、使用 CONUT 工具进行的营养评估、叶酸、维生素 D 缺乏症、既往骨折、视力下降、肱骨周径、肌肉疏松症和骨质疏松症(股骨颈密度测量)。营养状况(OR:0.08 [0.01-0.61])、叶酸水平(OR 0.32 [0.1-1])和视力丧失(OR 33.16 [2.91-377.87])是与髋部骨折相关的独立风险因素。这些工具可有效帮助识别髋部骨折高危人群,从而有助于采取更有针对性和更有效的预防措施。
{"title":"Factores predictivos del riesgo de fractura de cadera osteoporótica en octogenarios","authors":"A. Capdevila-Reniu ,&nbsp;M. Navarro-López ,&nbsp;V. Sapena ,&nbsp;A.I. Jordan ,&nbsp;M. Arroyo-Huidobro ,&nbsp;A. López-Soto","doi":"10.1016/j.rce.2023.11.010","DOIUrl":"10.1016/j.rce.2023.11.010","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to identify the risk factors associated with osteoporotic hip fractures in octogenarians and seeks to refine primary prevention strategies for these fractures.</p></div><div><h3>Material and methods</h3><p>We conducted a case–control study involving individuals aged 79 years and older with hip fractures, comparing them to age- and sex-matched controls without a history of hip fractures. We collected epidemiological, clinical, anthropometric, and analytical factors. We evaluated the presence of osteoporosis using bone densitometry. We defined sarcopenia according the European Working Group on Sarcopenia in Older People criteria (EWGSOP2).</p></div><div><h3>Results</h3><p>Ninety-five patients per group were analyzed, with a mean age of 82 years, of which 74% were women. The multivariate analysis included statistically significant factors found in the univariate analysis (<em>P</em><span>&lt;</span>.05). These factors included the Barthel Index, nutritional assessment using the CONUT tool, folic acid, vitamin D deficiency, presence of previous fractures, loss of visual acuity, bicipital circumference, sarcopenia, and osteoporosis (densitometry in the neck of the femur). The nutritional state (OR: 0.08 [0.01–0.61]), the folic acid levels (OR 0.32 [0.1–1]), and a loss of visual acuity (OR 33.16 [2.91–377.87]) were the independent risk factors associated with hip fracture.</p></div><div><h3>Conclusions</h3><p>The assessment of nutritional status in elderly patients, coupled with a comprehensive geriatric assessment, represents easily reproducible and cost-effective tools. These tools can effectively aid in identifying individuals at risk of hip fractures, thereby contributing to more targeted and efficient preventive measures.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139635787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista clinica espanola
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1